echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Nature Medicine: Pressed the reset button for autoimmune diseases

    Nature Medicine: Pressed the reset button for autoimmune diseases

    • Last Update: 2022-10-01
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Patients with severe autoimmune diseases are being treated with genetically modified cells from the body, known as CAR-T cells
    .


    "CAR stands for Chimeric Antigen Receptor, which is an artificial receptor," explains Professor Andreas Mackensen, "Immune cells or T cells extracted from a patient are genetically engineered in the laboratory to be added to CAR
    .


    In patients with autoimmune diseases, CAR-T cells are programmed to make B cells harmless, and B cells form antibodies
    to their own cells.


    Systemic lupus erythematosus (SLE), also known as red wolf disease, is a serious autoimmune disease that most often occurs in young women and forms antibodies that attack the body's DNA
    .


    "We have been able to help six young patients with life-threatening systemic lupus erythematosus and completely cure their disease with CAR-T cell therapy," said
    Professor Georg Schett, chair of the Department of Rheumatology and Immunology Medicine.


    Professor Dimitros Mougiakakos, an CAR-T cell specialist from the University of Magdeburg, who was also involved in the study, spoke about the "reset button"
    activated by CAR-T cells in the immune system of affected patients.


    Treatment is carried out at the German Immunotherapy Center (DZI) in Erlangen, by the 1181 Cooperative Research Center (Inflammation Resolution Checkpoint; Speaker: Professor Georg Schett
    ).
    Scientists are planning a package of clinical trials in early 2023, when patients with various serious autoimmune diseases will be able to receive treatment
    with CAR-T cells.


    essay

    Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.